Voyageur Pharmaceuticals (CVE:VM) Shares Down 33.3% – Should You Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) fell 33.3% on Wednesday . The company traded as low as C$0.14 and last traded at C$0.16. 1,601,925 shares traded hands during mid-day trading, an increase of 200% from the average session volume of 534,757 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Trading Down 31.3 %

The firm has a market capitalization of C$23.01 million, a PE ratio of -16.50 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The company has a fifty day moving average of C$0.10 and a 200-day moving average of C$0.07.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.